and €10 million in Lyon Gerland to produce Tzield (teplizumab), a biologic for type 1 diabetes that Sanofi acquired last year from Provention Bio in a $2.9 billion deal. “With these ...

This month on pharmaphorum, we explore the history of French pharmaceutical company Sanofi, which was created through many partnerships and acquisitions over a period of 100 years. Sanofi is one ...

Hamas proposed releasing all hostages for a lasting truce. It also rejected Israel's call for its disarmament and removal from Gaza. Rebuilding Gaza could cost $53.2 billion, according to ...

Sanofi India Ltd., incorporated in the year 1956, is a Mid Cap company (having a market cap of Rs 12,048.93 Crore) operating in Pharmaceuticals sector. Sanofi India Ltd. key Products/Revenue Segments ...

The Lyon Consensus provides conclusive criteria for and against the diagnosis of gastro-oesophageal reflux disease (GERD), and adjunctive metrics that consolidate or refute GERD diagnosis when primary ...

While they still trade at premium valuations, they have not created much wealth for shareholders in recent times. The age-old theory that having MNC stocks in your portfolio is an assurance of growth ...

Brian Feth, Jonathan Grinstein, PhD, Beth Willers, and Laks Pernenkil go behind the headlines to discuss major news announcements made during the JP Morgan Healthcare Conference, a wave of new ...

The platform is live with full functionality for use by marketing authorization holders and national competent authorities to report drug supply information.